Literature DB >> 3691293

Plasma fluorescein decay determination during fluorophotometry.

J P Boot1, J A Van Best, E W Tjin a Tsoi, J P Kappelhof, J A Oosterhuis.   

Abstract

Two useful methods for determination of the decay curve of non-protein bound fluorescein (NPBF) in plasma up to 1 hour after intravenous fluorescein injection are described and evaluated. The course of NPBF is approximated in method 1 by a sum of two exponential decay functions and in method 2 by a power of time function. The parameters in these functions are calculated with the use of concentration values measured in two blood samples taken at about 5 min. and 60 min. after injection. Calculations in method 1 include the amount of fluorescein injected. The accuracy of each method was evaluated in 7 volunteers by measuring NPBF concentration in 15-28 blood samples taken after fluorescein injection at intervals of 5 min. or less. The mean relative deviation between calculated and measured concentration values amounted to 9.2% +/- 4.3 SD and 12.7% +/- 4.5 SD for method 1 and 2, respectively. The time integral of NPBF concentration in plasma up to one hour after injection was calculated according to the results of both methods and compared with integral values obtained by linear interpolation between concentration values measured in the 15-28 plasma samples. The mean relative deviation for the 7 volunteers amounted at 15 min. to 2.8% and 17% and at 60 min. to 11% and 18% for method 1 and 2, respectively. The maximal difference between the blood-retinal barrier permeability value for NPBF calculated with and without taking glucuronation into account was estimated to be 20% for an average glucuronation percentage of 70% or less.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3691293     DOI: 10.1007/bf00143044

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  24 in total

1.  Blood aqueous barrier permeability versus age by fluorophotometry.

Authors:  J A van Best; J P Kappelhof; L Laterveer; J A Oosterhuis
Journal:  Curr Eye Res       Date:  1987-07       Impact factor: 2.424

2.  Inward permeability of the blood-retinal barrier by fluorophotometry.

Authors:  J P Kappelhof; J A van Best; P L van Valenberg; J A Oosterhuis
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-04       Impact factor: 4.799

3.  Binding of fluorescein monoglucuronide to human serum albumin.

Authors:  S Nagataki; I Matsunaga
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-08       Impact factor: 4.799

4.  Early breakdown of the blood-retinal barrier in diabetes.

Authors:  J Cunha-Vaz; J R Faria de Abreu; A J Campos
Journal:  Br J Ophthalmol       Date:  1975-11       Impact factor: 4.638

5.  Red cell and plasma volumes in normal adults.

Authors:  P J Hurley
Journal:  J Nucl Med       Date:  1975-01       Impact factor: 10.057

6.  Ocular fluorophotometry in patients with essential hypertension.

Authors:  F Kayazawa; K Miyake
Journal:  Arch Ophthalmol       Date:  1984-08

7.  Fluorescein in human plasma in vitro.

Authors:  H Lund-Andersen; B Krogsaa
Journal:  Acta Ophthalmol (Copenh)       Date:  1982-10

8.  Fluorescein in human plasma in vivo.

Authors:  H Lund-Andersen; B Krogsaa; P K Jensen
Journal:  Acta Ophthalmol (Copenh)       Date:  1982-10

9.  Measurement of blood-retinal barrier permeability: a reproducibility study in normal eyes.

Authors:  P S Chahal; P J Chowienczyk; E M Kohner
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-07       Impact factor: 4.799

10.  Fluorescein and fluorescein glucuronide pharmacokinetics after intravenous injection.

Authors:  N P Blair; M A Evans; T S Lesar; R C Zeimer
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-07       Impact factor: 4.799

View more
  8 in total

1.  Spectrophotometric analysis of sodium fluorescein aqueous solutions. Determination of molar absorption coefficient.

Authors:  M C Mota; P Carvalho; J Ramalho; E Leite
Journal:  Int Ophthalmol       Date:  1991-09       Impact factor: 2.031

2.  Diffusion coefficient through the blood-aqueous barrier using a standard protocol.

Authors:  J van Best; J B del Castillo; M Diestelhorst; B Heintz; E Leite; L F Liesenborghs; R Schalnus
Journal:  Br J Ophthalmol       Date:  1996-04       Impact factor: 4.638

3.  Permeability of the blood-retinal barrier in healthy humans. European Concerted Action on Ocular Fluorometry.

Authors:  H J Van Schaik; B Heintz; M Larsen; E Leite; V Rosas; R Schalnus; J A Van Best
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-10       Impact factor: 3.117

4.  Effect of beta-irradiation by a 106 ruthenium plaque on the rabbit eye choroid.

Authors:  D F Schaling; P K Lommatzsch; J L van Delft; D de Wolff-Rouendaal; J A van Best; J A Oosterhuis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

5.  Blood-retinal and blood-aqueous barrier permeability, lens autofluorescence and transmission in insulin-dependent diabetic youngsters.

Authors:  E van Wirdum; J van Best; G J Bruining; C de Beaufort; J Oosterhuis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

6.  Effects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trial.

Authors:  J M van Gerven; J P Boot; H H Lemkes; J A van Best
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

7.  Effect of morphological abnormalities on blood retinal barrier permeability in diabetic retinopathy.

Authors:  J M van Gerven; J P Boot; H H Lemkes; J A van Best
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

8.  Blood retinal and blood aqueous barriers in diabetics by fluorophotometry.

Authors:  J P Boot; J M van Gerven; J A van Best; L Vrij; H H Lemkes; J A Oosterhuis
Journal:  Doc Ophthalmol       Date:  1989-01       Impact factor: 2.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.